TY - JOUR
T1 - The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly
AU - Hoshida, Y.
AU - Ikeda, K.
AU - Saito, S.
AU - Kobayashi, M.
AU - Kobayashi, M.
AU - Suzuki, Y.
AU - Tsubota, A.
AU - Koida, I.
AU - Arase, Y.
AU - Murashima, N.
AU - Chayama, K.
AU - Kumada, H.
PY - 1999
Y1 - 1999
N2 - Four hundred and twenty-one patients with hepatocellular carcinoma who firstly underwent transcatheter arterial chemoembolization were divided into three groups as 'younger' (32-69 yr-old, n = 340), 'elderly' (70-79 yr-old, n = 74) and 'super-elderly' (80-89 yr-old, n = 7). Between 'younger' and 'elderly', clinical stage of underlying liver disease, stage of hepatocellular carcinoma and tumor necrosis rate at first treatment did not differ significantly. In these two groups, the first year survival rates were 83.2, 79.7%, the third year survival rates were 47.2, 36.5% and the fifth year survival rates were 22.9, 14.5% respectively. Cumulative survival rate of the 'elderly' was similar to the 'younger'. Factors significantly affecting the survival period included advanced clinical stage of underlying liver disease and hepatocellular carcinoma, poor tumor necrosis at the first treatment and high serum α-fetoprotein level in the 'younger' and high α- fetoprotein, advanced stage of hepatocellular carcinoma and presence of other than liver disease in 'elderly'. Transarterial chemoembolization is useful for the treatment of hepatocellular carcinoma in the 'elderly' with the attention for their underlying diseases.
AB - Four hundred and twenty-one patients with hepatocellular carcinoma who firstly underwent transcatheter arterial chemoembolization were divided into three groups as 'younger' (32-69 yr-old, n = 340), 'elderly' (70-79 yr-old, n = 74) and 'super-elderly' (80-89 yr-old, n = 7). Between 'younger' and 'elderly', clinical stage of underlying liver disease, stage of hepatocellular carcinoma and tumor necrosis rate at first treatment did not differ significantly. In these two groups, the first year survival rates were 83.2, 79.7%, the third year survival rates were 47.2, 36.5% and the fifth year survival rates were 22.9, 14.5% respectively. Cumulative survival rate of the 'elderly' was similar to the 'younger'. Factors significantly affecting the survival period included advanced clinical stage of underlying liver disease and hepatocellular carcinoma, poor tumor necrosis at the first treatment and high serum α-fetoprotein level in the 'younger' and high α- fetoprotein, advanced stage of hepatocellular carcinoma and presence of other than liver disease in 'elderly'. Transarterial chemoembolization is useful for the treatment of hepatocellular carcinoma in the 'elderly' with the attention for their underlying diseases.
UR - http://www.scopus.com/inward/record.url?scp=0033066180&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033066180&partnerID=8YFLogxK
M3 - Article
C2 - 10087885
AN - SCOPUS:0033066180
SN - 0446-6586
VL - 96
SP - 142
EP - 146
JO - Japanese Journal of Gastroenterology
JF - Japanese Journal of Gastroenterology
IS - 2
ER -